NO943372L - Behandling av migrene - Google Patents

Behandling av migrene

Info

Publication number
NO943372L
NO943372L NO943372A NO943372A NO943372L NO 943372 L NO943372 L NO 943372L NO 943372 A NO943372 A NO 943372A NO 943372 A NO943372 A NO 943372A NO 943372 L NO943372 L NO 943372L
Authority
NO
Norway
Prior art keywords
migraine
treatment
blocking agent
administered
aura
Prior art date
Application number
NO943372A
Other languages
English (en)
Norwegian (no)
Other versions
NO943372D0 (no
Inventor
Arthur M Goldberg
Leonard Lachman
Original Assignee
Rugby Darby Group Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rugby Darby Group Co Inc filed Critical Rugby Darby Group Co Inc
Publication of NO943372D0 publication Critical patent/NO943372D0/no
Publication of NO943372L publication Critical patent/NO943372L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Disintegrating Or Milling (AREA)
NO943372A 1992-03-13 1994-09-12 Behandling av migrene NO943372L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/850,566 US5242949A (en) 1992-03-13 1992-03-13 Treating classic migraine
PCT/US1993/002132 WO1993017672A1 (en) 1992-03-13 1993-03-08 Treatment of migraine

Publications (2)

Publication Number Publication Date
NO943372D0 NO943372D0 (no) 1994-09-12
NO943372L true NO943372L (no) 1994-11-14

Family

ID=25308498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943372A NO943372L (no) 1992-03-13 1994-09-12 Behandling av migrene

Country Status (18)

Country Link
US (1) US5242949A (de)
EP (1) EP0727986B1 (de)
JP (1) JP2839207B2 (de)
KR (1) KR950701215A (de)
AT (1) ATE193441T1 (de)
AU (1) AU675931B2 (de)
CA (1) CA2131991C (de)
DE (1) DE69328792T2 (de)
DK (1) DK0727986T3 (de)
ES (1) ES2148222T3 (de)
FI (1) FI944236A7 (de)
GR (1) GR3034188T3 (de)
HU (1) HUT71834A (de)
MX (1) MX9301393A (de)
NO (1) NO943372L (de)
PH (1) PH30101A (de)
PT (1) PT727986E (de)
WO (1) WO1993017672A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408026A (en) * 1993-08-23 1995-04-18 Cowan; Patrick J. Curable and cured organosilicon compositions, and process for making same
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20080226715A1 (en) * 2007-03-16 2008-09-18 Albert Cha Therapeutic compositions and methods
WO2009103150A1 (en) * 2008-02-20 2009-08-27 Kevin David Smith Method for treating migraine headaches
WO2013016223A2 (en) 2011-07-22 2013-01-31 The University Of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same

Also Published As

Publication number Publication date
JPH08500329A (ja) 1996-01-16
FI944236A0 (fi) 1994-09-13
FI944236L (fi) 1994-11-11
GR3034188T3 (en) 2000-11-30
WO1993017672A1 (en) 1993-09-16
JP2839207B2 (ja) 1998-12-16
EP0727986A4 (de) 1995-04-25
PH30101A (en) 1996-12-27
DE69328792D1 (de) 2000-07-06
AU3799193A (en) 1993-10-05
EP0727986A1 (de) 1996-08-28
MX9301393A (es) 1994-08-31
NO943372D0 (no) 1994-09-12
HU9402612D0 (en) 1994-11-28
KR950701215A (ko) 1995-03-23
PT727986E (pt) 2000-11-30
CA2131991A1 (en) 1993-09-16
CA2131991C (en) 1999-07-06
DK0727986T3 (da) 2000-10-30
ES2148222T3 (es) 2000-10-16
FI944236A7 (fi) 1994-11-11
HUT71834A (en) 1996-02-28
AU675931B2 (en) 1997-02-27
EP0727986B1 (de) 2000-05-31
US5242949A (en) 1993-09-07
ATE193441T1 (de) 2000-06-15
DE69328792T2 (de) 2001-02-01

Similar Documents

Publication Publication Date Title
EP1086702A3 (de) Botulinustoxine gegen Migränekopfschmerzen
AR035158A1 (es) Inhibidores de recaptacion de norepinefrina altamente selectivos y metodo para usar los mismos
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
NO943372L (no) Behandling av migrene
NO983636D0 (no) Fremgangsmåte for behandling av trekninger og sykdomstilstander i sentralnervesystemet ved anvendelse av optisk rent (+) norcisaprid
SE9603725D0 (sv) New teatment
NO984446L (no) FremgangsmÕte for behandling av smerte
NO984245L (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
SE9902597D0 (sv) New use
DK89697A (da) Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed
SE0002353D0 (sv) New use
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
IS6017A (is) Aðferð til meðhöndlunar á höfuðverk
NO984190L (no) FremgangsmÕte for behandling av insomnia
NO984198L (no) FremgangsmÕte for behandling av aggresjon
FR2718965B1 (fr) Nouvelle application thérapeutique de la spiramycine.
DK1304107T3 (da) Anvendelse af oxozolidinonderivater til behandling af psoriasis
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA36251A (uk) Спосіб комплексної терапії простої шизофренії